Work

Supplementary Data from Temozolomide Sensitizes ARID1A-Mutated Cancers to PARP Inhibitors

Year: 2024

Type: supplementary-materials

Abstract: Supplementary Figures

Authors: Zheng-Cheng Yu, Tianhe Li, Ellen Tully, Peng Huang, Chih-Ning Chen, Philipp Oberdoerffer, Stephanie Gaillard, Ie-Ming Shih, Tian-Li Wang

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4402798996

Cites:

Cited by:

Related to: 10